Published on: August 11, 2019
by Mental Daily:
Depressive symptoms might be an early risk factor of Alzheimer’s disease before the exhibition of cognitive deficits, a new study shows.
The study, conducted at Massachusettes General Hospital (MGH), demonstrated how depressive symptoms in patients with brain amyloid deposition could impact cognitive abilities among healthy older adults. Although previous research extensively covered the connection between depression and cognitive decline, the new findings are the first to point out its influence on cortical amyloid in healthy older adults, despite minimal depressive symptoms.
As part of the study, published in JAMA Network Open, a team of researchers collected data from 276 older adults over a span of seven years, all of which participated in the Harvard Aging Brain Study. Analyzing this data led the team to the unraveling of a link between declining depressive symptoms and cognitive abilities over a span of two to seven years. The changes, consisting of brain amyloid deposition, were measured through PET imaging.
“Our research found that even modest levels of brain amyloid deposition can impact the relationship between depression symptoms and cognitive abilities. This raises the possibility that depression symptoms could be targets in clinical trials aimed at delaying the progression of Alzheimer’s disease,” said Jennifer Gatchel, lead author of the study.
“Our findings offer evidence that in healthy older adults, depression symptoms together with brain amyloid may be associated with early changes in memory and in thinking,” Gatchel added. “Depression symptoms themselves may be among the early changes in the preclinical stages of dementia syndromes. Just as importantly, these stages represent a clinical window of opportunity for closely monitoring at-risk individuals, and for potentially introducing interventions to prevent or slow cognitive decline.”
“These findings underscore the fact that depression symptoms are multi-factorial and may actually work synergistically with amyloid and related processes to affect cognition over time in older adults. This is an area we will continue to actively study,” Gatchel concluded.
Thanks to the ongoing support of our partner Brain Canada, and The Citrine Foundation of Canada, Women’s Brain Health Initiative’s newest edition of MIND OVER MATTER has just been published. Loaded with interesting science-based articles, MIND OVER...
On December 2nd, in celebration of Women’s Brain Health Day, join thousands of others and take part in the Stand Ahead® Memory Challenge to stand up against research bias and stand ahead for women’s brain...
YOU’RE INVITED! On December 2nd, the second annual Women’s Brain Health Day, take the memory challenge and help us combat brain-aging diseases that disproportionately affect women. Join CTV’s Pattie Lovett-Reid and Anne-Marie Mediwake, along...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.